Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION

v3.20.1
STOCK-BASED COMPENSATION
3 Months Ended
Feb. 29, 2020
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION [Text Block]

6.          STOCK-BASED COMPENSATION

2017 Plan

The Company grants stock options and other stock-based awards under its 2017 Stock Option Plan (the "2017 Plan"). All stock option awards granted to employees are valued at fair value by using either the Black-Scholes or Binomial Lattice option pricing models and recognized on a straight-line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from non-employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration for employees and non-employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services.

 

During the three months ended February 29, 2020, the Company granted options to purchase 3,917,500 shares of common stock to its employees and directors. The Company recorded stock-based compensation expense for options granted to its employees and directors of $602,108 and $4,227 during the three months ended February 29, 2020 and February 28, 2019, respectively.

 

During the three months ended February 29, 2020, the Company granted options to purchase 110,000 shares of common stock to non-employees (consultants). The Company recorded stock-based compensation expense for options granted to non-employees of  $19,244  and $Nil  during the three months ended February 29, 2020 and February 28, 2019, respectively.

 

Stock Option Valuation

The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and non-employees for the three months ended February 29, 2020 were as follows:

 

Three Months Ended February 29, 2020
 

Employee, Director and Non-Employee Options (Black-Scholes option pricing model)

 

Risk free rate     1.07—1.68 %
Expected dividends     0 %
Expected volatility     143.90—144.28 %
Expected life     5 years  
Market price of the Company’s common stock on date of grant   $ 0.19  

Exercise price

  $ 0.19  

 

 

 

 

 

The following table summarizes option activity under the 2017 Plan during the three months ended February 29, 2020:

    Stock     Weighted Average
Exercise Price Per Stock
Option 
 
    Options     CDN$     USD$  
Outstanding, November 30, 2019   2,911,667     0.19     0.14  
Granted   4,027,500     0.25     0.19  
Expired   (50,000 )   (0.38 )   (0.29 )
Cancelled            
Outstanding, February 29, 2020   6,889,167     0.23     0.17  
Exercisable, February 29, 2020   4,889,167     0.23     0.17  

 

 

 

 

 

 

 

 

 

Incentive Warrants

During the year ended November 30, 2019, the Company issued 750,000 warrants each to two consultants (the "Incentive Warrants") to purchase common shares. The Incentive Warrants were issued outside of the 2017 Plan and became fully vested in December 2019.

 

During the three months ended February 29, 2020, the Company issued 150,000 warrants in exchange for services to a marketing consultant to purchase common shares. The warrants were issued outside of the 2017 Plan and were fully vested as of February 29, 2020.

 

Stock-based compensation expense for the three months ended February 29, 2020 and February 28, 2019 was $15,434 and $119,440, respectively.

 

The assumptions the Company used to determine the grant-date fair value of warrants granted to the marketing consultant during the three months ended February 29, 2020 were as follows:

 

Risk free rate   1.47%  
Expected dividends   0%  
Expected volatility   56.92 %  
Expected life   1.1 years  
Market price of the Company’s common stock on date of grant $  0.22  

Exercise price

$   0.25 

 

 

 

 

 

 

 

Stock-Based Compensation Expense

 

Total stock-based compensation expense of $636,786 and $123,667 for the three months ended February 29, 2020 and February 28, 2019, respectively, were recorded in SG&A expenses.